Approval · Notice of Compliance 24899 · 2020
ESSEPNA: Notice of Compliance 24899
Issued December 30, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 24899
- Date
- December 30, 2020
- Company
- Fresenius Kabi Canada LtdToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ESSEPNA | 02510324 | Marketed |
Medicinal ingredients
- L-ALANINE 14 MG per ML
- GLYCINE 11 MG per ML
- HISTIDINE 3 MG per ML
- L-ARGININE 12 MG per ML
- L-ISOLEUCINE 5 MG per ML
- L-LEUCINE 7.4 MG per ML
- L-PHENYLALANINE 5.1 MG per ML
- L-PROLINE 11.2 MG per ML
- L-THREONINE 4.4 MG per ML
- L-TRYPTOPHAN 2 MG per ML
- L-VALINE 6.2 MG per ML
- L-LYSINE ACETATE 9.3 MG per ML
- METHIONINE 4.3 MG per ML
- SERINE 6.5 MG per ML
- TAURINE 1 MG per ML
- L-TYROSINE 0.4 MG per ML